BioCentury | Oct 18, 2012
Financial News

Genmedica raises EUR 12M in B round

...Spanish investors. Caixa Capital led the round, with which included participation by BcnEmpren; Unifondo-Uninvest; and Venture Cap. BC...
BioCentury | Feb 19, 2007
Finance

Ebb & Flow

When Invitrogen bought BioReliance for $500 million in cash in early 2004, the rationale was clear: make a bioproduction powerhouse by coupling services with products. The deal combined IVGN's media, sera, reagents, packaging and cell...
Items per page:
1 - 2 of 2
BioCentury | Oct 18, 2012
Financial News

Genmedica raises EUR 12M in B round

...Spanish investors. Caixa Capital led the round, with which included participation by BcnEmpren; Unifondo-Uninvest; and Venture Cap. BC...
BioCentury | Feb 19, 2007
Finance

Ebb & Flow

When Invitrogen bought BioReliance for $500 million in cash in early 2004, the rationale was clear: make a bioproduction powerhouse by coupling services with products. The deal combined IVGN's media, sera, reagents, packaging and cell...
Items per page:
1 - 2 of 2